Muscle weakness after administration of neuromuscular blocking agents: do not immobilize the diaphragm unnecessarily

Crit Care Med. 2007 Jun;35(6):1634-5; author reply 1635. doi: 10.1097/01.CCM.0000266804.62808.2B.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Androstanols / adverse effects*
  • Animals
  • Diaphragm / drug effects*
  • Diaphragm / pathology
  • Diaphragm / physiopathology
  • Muscular Atrophy / etiology
  • Muscular Atrophy / pathology
  • Muscular Atrophy / physiopathology
  • Neuromuscular Nondepolarizing Agents / adverse effects*
  • Rats
  • Respiration, Artificial / adverse effects*
  • Rocuronium

Substances

  • Androstanols
  • Neuromuscular Nondepolarizing Agents
  • Rocuronium